High Doses of Clopidogrel to Overcome Genetic Resistance
Authors:
- Jean-Sébastien HulotJHJean-Sébastien Hulot
- Ghalia AnzahaGAGhalia Anzaha
- Ana PenaAPAna Pena
- Thomas ChastreTCThomas Chastre
- Claire CaronCCClaire Caron
- Johanne SilvainJSJohanne Silvain
- Guillaume CaylaGCGuillaume Cayla
- Anne Bellemain-AppaixABAnne Bellemain-Appaix
- Jean-Baptiste VignalouJVJean-Baptiste Vignalou
- Sophie GalierSGSophie Galier
- Olivier BarthélémyOBOlivier Barthélémy
- 1 April 2011
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 4 (4) , 392-402
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
- Fédération Française de Cardiologie
- AstraZeneca
- Fondation de France
- Bayer
- Ministère des Affaires Sociales et de la Santé (PHRC P070117)
- Cardiovascular Research Foundation
- Biotronik
- Société Française de Cardiologie
- Institut National de la Santé et de la Recherche Médicale
- Medco Research Institute
This publication has 23 references indexed in Scilit:
- An improved method for specific and quantitative determination of the clopidogrel active metabolite isomers in human plasmaThrombosis and Haemostasis, 2011
- Carriage of Cytochrome 2C19 Polymorphism Is Associated With Risk of High Post-Treatment Platelet Reactivity on High Maintenance-Dose Clopidogrel of 150 mg/dayJACC: Cardiovascular Interventions, 2010
- Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor CoadministrationJACC, 2010
- Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active MetaboliteDrug Metabolism and Disposition, 2010
- Can We Override Clopidogrel Resistance?Circulation, 2009
- Dose Effect of Clopidogrel Reloading in Patients Already on 75-mg Maintenance DoseCirculation, 2008
- Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrelJournal of Thrombosis and Haemostasis, 2007
- Absorption, Metabolization, and Antiplatelet Effects of 300-, 600-, and 900-mg Loading Doses of ClopidogrelCirculation, 2005
- Matching the Evaluation of the Clinical Efficacy of Clopidogrel to Platelet Function Tests Relevant to the Biological Properties of the DrugJACC, 2005
- Clinical Significance of the Cytochrome P450 2C19 Genetic PolymorphismClinical Pharmacokinetics, 2002